Citation Impact
Citing Papers
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
2009 StandoutNobel
Sialylation of 3-Methylcholanthrene–Induced Fibrosarcoma Determines Antitumor Immune Responses during Immunoediting
2010
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Engineering precision nanoparticles for drug delivery
2020 Standout
Altered immune responses in mice lacking inducible nitric oxide synthase
1995 StandoutNature
Impaired immune and acute-phase responses in interleukin-6-deficient mice
1994 StandoutNatureNobel
Pancreatic cancer
2004 Standout
Necroptosis and its role in inflammation
2015 StandoutNature
Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo
1999 Standout
Nucleotide signalling during inflammation
2014 StandoutNature
Extracellular adenosine triphosphate and adenosine in cancer
2010
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
1995 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Renal-Cell Carcinoma
1996 Standout
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
1999 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Use of tumour-responsive T cells as cancer treatment
2009
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Noncovalent drug-DNA binding interactions that inhibit and stimulate (A)BC excinuclease
1991 StandoutNobel
A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines.
1991 StandoutNobel
Immunity, Inflammation, and Cancer
2010 Standout
Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy
2016
Cardiotoxicity of Chemotherapeutic Agents
2000
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Spermine Induces Maturation of the Immature Intestinal Immune System in Neonatal Mice
1997
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
Stem Cell-derived Neural Stem/Progenitor Cell Supporting Factor Is an Autocrine/Paracrine Survival Factor for Adult Neural Stem/Progenitor Cells
2003 StandoutNobel
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
2002 Standout
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
2007
Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells
1991
How TNF was recognized as a key mechanism of disease
2007
Macrophage biology in development, homeostasis and disease
2013 StandoutNature
Tumor necrosis factor Characterization at the molecular, cellular and in vivo level
1991
Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice
2003 StandoutNobel
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways
1996 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Primary Antitumor Immune Response Mediated by CD4+ T Cells
2005
GM-CSF-based cellular vaccines: a review of the clinical experience
2002
Nonspecific defence mechanism: the role of nitric oxide
1991
Tumor Angiogenesis
2008 Standout
Pancreatic cancer
2011 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice.
2001
Anticancer Activity Expressed by a Library of 2,9-Diazaperopyrenium Dications
2015 StandoutNobel
Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials
2019
Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity.
1994
Secretome Analysis of Multiple Pancreatic Cancer Cell Lines Reveals Perturbations of Key Functional Networks
2010
Induction of Tumor Immunity by Removing CD25+CD4+ T Cells: A Common Basis Between Tumor Immunity and Autoimmunity
1999 StandoutNobel
Gene expression profiling of monocyte-derived macrophages following infection withMycobacterium aviumsubspeciesaviumandMycobacterium aviumsubspeciesparatuberculosis
2006
Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes
1990
Genetic analysis of the human tumor necrosis factor alpha/cachectin promoter region in a macrophage cell line.
1989
Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation
2011
The two different receptors for tumor necrosis factor mediate distinct cellular responses.
1991
Nonintercalating DNA-binding ligands: Specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material
1986
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.
1992
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
2010
Spermidine in health and disease
2018 StandoutScience
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
2015
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
2016
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
1993 StandoutScience
Multiple Click-Selective tRNA Synthetases Expand Mammalian Cell-Specific Proteomics
2018 StandoutNobel
Metabolism of ubiquitinated histones.
1981 StandoutNobel
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
1991 Standout
Glucocorticoid-Induced TNF Receptor Family Related Gene Activation Overcomes Tolerance/Ignorance to Melanoma Differentiation Antigens and Enhances Antitumor Immunity
2006 StandoutNobel
C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells
2010
Works of M. Jane Ehrke being referenced
Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-α therapy: Phenotypic and functional characterization up to 20 months after initial tumor inoculation
1998
Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance
1996
Ecto‐5'‐nucleotidase (CD73) in multidrug‐resistant cell lines generated by doxorubicin
1994
Species-specific TNF induction of thymocyte proliferation
1988
A novel TNF-inducible message with putative growth suppressor function
1999
Adriamycin-induced modulation of host defenses in tumor-bearing mice.
1992
Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice.
1986
Alterations in murine host defense functions by adriamycin or liposome-encapsulated adriamycin.
1988
Studies on the structure—activity relationship among aliphatic and aromatic bisguanylhydrazones and some related compounds
1977
Effects of anticancer drugs on the immune system in humans.
1989
Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha.
1992
Intracellular doxorubicin kinetics in lymphoma cells and lymphocytes infiltrating the tumor area in vivo: a flow cytometric study.
1994
Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon.
1987
Immunological responses critical to the therapeutic effects of adriamycin plus interleukin 2 in C57BL/6 mice bearing syngeneic EL4 lymphoma.
1993
Role of tumor necrosis factor in macrophage activation and tumoricidal activity.
1988
Selective modulation by alpha-difluoromethylornithine of T-lymphocyte and antibody-mediated cytotoxic responses to mouse tumor allografts.
1986
Doxorubicin-induced DNA degradation in murine thymocytes.
1994
Modification of host antitumor defense mechanisms in mice by progressively growing tumor.
1989
Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
1989
Doxorubicin plus Interleukin-2 Chemoimmunotherapy against Breast Cancer in Mice
2006
Changes in cytosol and membrane TNF inhibitory protein‐B1 levels associated with protection from TNF‐induced cytotoxicity
2001
Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma.
2006